Who
Malte Peters
President & CEO
Company insider
Files Form 4 as: President & CEO, Tango Therapeutics; Chief Executive Officer, HOOKIPA Pharma.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $47K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 8 Jun 2022
- Last trade
- 8 Jan 2026
- Last filed
- 12 Jan 2026
Companies traded
Activity over time
1 Jul 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jan 2026filed 12 Jan 2026 | TNGX Tango TherapeuticsBiotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | TNGX Tango Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,650,000 at $0.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | TNGX Tango Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,650,000 at $0.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | TNGX Tango TherapeuticsBiotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 3 Nov 2025filed 4 Nov 2025 | TNGX Tango Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 19 Aug 2025filed 9 Oct 2025 | HOOKIPA Pharma | SEC FORM 4 Sold | $21K25,172 at $0.82 | filing |
| 22 Jul 2025filed 23 Jul 2025 | HOOKIPA Pharma | SEC FORM 4 Sold | $27K29,176 at $0.92 | filing |
| 5 Jun 2025filed 9 Jun 2025 | TNGX Tango Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | TNGX Tango TherapeuticsBiotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 22 Jul 2024filed 24 Jul 2024 | HOOKIPA Pharma | SEC FORM 4 Code A | —108,695 at $0.00 | filing |
| 17 Jun 2024filed 18 Jun 2024 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code A | —49,000 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | TNGX Tango Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | TNGX Tango TherapeuticsBiotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 9 Jun 2023filed 9 Jun 2023 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code A | —52,000 at $0.00 | filing |
| 6 Jun 2023filed 8 Jun 2023 | TNGX Tango Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 6 Jun 2023filed 8 Jun 2023 | TNGX Tango TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 8 Jun 2022filed 28 Jun 2022 | TNGX Tango Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.